Genomic insights into blaAFM-positive carbapenem-resistant Pseudomonas aeruginosa in China
Carbapenem-resistant <i>Pseudomonas aeruginosa</i> (CRPA) poses a global threat; however, the epidemiological characteristics and clinical significance of <i>bla</i> <sub>AFM</sub>-positive CRPA strains in China remain unclear. In this study, continuous surveillance was conducted from 2018 to 2022 in a hospital in Henan Province, China, and the genomic characteristics of <i>bla</i> <sub>AFM</sub>-positive CRPA were elucidated. We characterised the genetic features of <i>bla</i> <sub>AFM</sub>-positive CRPA isolates by antimicrobial susceptibility testing, conjugation assays, whole-genome sequencing, large-scale comparative genomics, and bioinformatic analyses. Among 628 CRPA isolates, one <i>bla</i> <sub>AFM</sub>-positive multidrug-resistant (MDR) strain, PA19-3158 (ST1123), was identified, with the <i>bla</i> <sub>AFM-1</sub> gene located on a novel 518,222 bp megaplasmid. Additionally, big data analysis revealed the genomic characteristics of <i>bla</i> <sub>AFM</sub>-positive CRPA across China. A total of three different <i>bla</i> <sub>AFM</sub> gene variants were identified among these isolates, namely <i>bla</i> <sub>AFM-1</sub> (44.12%), <i>bla</i> <sub>AFM-2</sub> (52.94%), and <i>bla</i> <sub>AFM-4</sub> (2.94%). Our findings identified ST463 as the dominant clone among <i>bla</i> <sub>AFM</sub>-positive CRPA in different regions of China, with some <i>bla</i> <sub>AFM</sub>-positive CRPA isolates from these regions exhibiting high genetic similarity. Notably, all <i>bla</i> <sub>AFM</sub>-positive CRPA isolates carried multiple antibiotic resistance genes (ARGs), with approximately 38% co-harboring the carbapenem-resistant gene <i>bla</i> <sub>KPC-2</sub> and approximately 47% co-harboring the tigecycline-resistant gene <i>tmexCD-toprJ</i>. Correlation analysis underscored the significant role of mobile genetic elements in facilitating <i>bla</i> <sub>AFM</sub> gene transfer. These results highlight the critical need for continuous surveillance of <i>bla</i> <sub>AFM</sub>-positive CRPA in clinical settings to mitigate potential risks.
Authors
- Shangshang Qin (ORCID: https://orcid.org/0000-0002-6017-6548)
- Huimin Lu (ORCID: https://orcid.org/0000-0001-9794-3221)
- Chuanjun Zhang
- Yan Li (ORCID: https://orcid.org/0000-0003-1963-839X)
- Zhao Bu-hui
Institutions
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.3389/fmicb.2025.1546662
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- National Supercomputing Center, Korea Institute of Science and Technology Information